Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AXIM BIOTECHNOLOGIES, INC. has filed 306 SEC EDGAR filings since 10 Mar 2011

SEC filing history

Showing 201-225 of 306 matching filings.

Per page
25
Current page
9
10-Q File 000-54296

FORM 10-Q QUARTERLY REPORT

Filing date
22 Aug 2016
Reporting date
30 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K CURRENT REPORT

Filing date
22 Aug 2016
Reporting date
29 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54296

FORM12B25 NOTICE OF LATE FILING

Filing date
16 Aug 2016
Reporting date
30 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-54296

FORM 10-Q A/1

Filing date
26 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
10-Q File 000-54296

FORM 10-Q

Filing date
23 May 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54296

FORM 12B-25

Filing date
13 May 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-54296

FORM 10-K (A/1)

Filing date
18 Apr 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
10-K File 000-54296

FORM 10-K (12-31-15)

Filing date
14 Apr 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-54296

NT 10-K

Filing date
30 Mar 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
19 Feb 2016
Reporting date
18 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
08 Feb 2016
Reporting date
25 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2016
Reporting date
05 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Dec 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Dec 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54296

FORM 10-Q (9-30-15)

Filing date
23 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
NT 10-Q File 000-54296

FORM 12B-25

Filing date
16 Nov 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
01 Sep 2015
Reporting date
26 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-54296

FORM 10-Q (A-1)

Filing date
27 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
10-Q File 000-54296

FORM 10-Q

Filing date
19 Aug 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54296

NT 10-Q

Filing date
14 Aug 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
06 Aug 2015
Reporting date
31 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
18 Jun 2015
Reporting date
18 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-204574

AXIM BIOTECHNOLOGIES, INC. 2015 STOCK INCENTIVE PLAN

Filing date
29 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54296

FORM 8-K

Filing date
14 May 2015
Reporting date
11 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .